This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
mRNA trans-splicing dual AAV vectors for (epi)genome editing and gene therapy
Nature Communications Open Access 18 October 2023
-
An efficient rAAV vector for protein expression in cortical parvalbumin expressing interneurons
Scientific Reports Open Access 25 October 2022
-
Maybe you can turn me on: CRISPRa-based strategies for therapeutic applications
Cellular and Molecular Life Sciences Open Access 12 February 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Ciulla TA, Hussain RM, Berrocal AM, Nagiel A. Voretigene neparvovec-rzyl for treatment of RPE65-mediated inherited retinal diseases: a model for ocular gene therapy development. Expert Opin Biol Ther. 2020; 20:565–78.
Trapani I, Auricchio A. Has retinal gene therapy come of age? From bench to bedside and back to bench. Hum Mol Genet. 2019;28:R108–R18.
Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019;18:358–78.
Trapani I, Auricchio A. Seeing the light after 25 years of retinal gene therapy. Trends Mol Med. 2018;24:669–81.
Chamberlain K, Riyad JM, Weber T. Expressing transgenes that exceed the packaging capacity of adeno-associated virus capsids. Hum Gene Ther Methods. 2016;27:1–12.
Tornabene P, Trapani I. Can adeno-associated viral vectors deliver effectively large genes? Hum Gene Ther. 2020;31:47–56.
McClements ME, MacLaren RE. Adeno-associated Virus (AAV) Dual Vector Strategies for Gene Therapy Encoding Large Transgenes. Yale J Biol Med. 2017;90:611–23.
Patel A, Zhao J, Duan D, Lai Y. Design of AAV vectors for delivery of large or multiple transgenes. Methods Mol Biol. 2019;1950:19–33.
Duan D, Yue Y, Engelhardt JF. Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison. Mol Ther. 2001;4:383–91.
Yan Z, Zhang Y, Duan D, Engelhardt JF. Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. Proc Natl Acad Sci USA. 2000;97:6716–21.
Ghosh A, Yue Y, Lai Y, Duan D. A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner. Mol Ther. 2008;16:124–30.
Trapani I. Adeno-associated viral vectors as a tool for large gene delivery to the retina. Genes (Basel). 2019;10:287.
Maddalena A, Tornabene P, Tiberi P, Minopoli R, Manfredi A, Mutarelli M, et al. Triple vectors expand AAV transfer capacity in the retina. Mol Ther. 2018;26:524–41.
Pasquini G, Cora V, Swiersy A, Achberger K, Antkowiak L, Muller B, et al. Using transcriptomic analysis to assess double-strand break repair activity: towards precise in vivo genome editing. Int J Mol Sci. 2020;21:1380.
Romero-Casanas A, Gordo V, Castro J, Ribo M. Protein splicing: from the foundations to the development of biotechnological applications. Methods Mol Biol. 2020;2133:15–29.
Aranko AS, Volkmann G. Protein trans-splicing as a protein ligation tool to study protein structure and function. Biomol Concepts. 2011;2:183–98.
Tornabene P, Trapani I, Minopoli R, Centrulo M, Lupo M, de Simone S, et al. Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina. Sci Transl Med. 2019;11:eaav4523.
Schmelas C, Grimm D. Split Cas9, not hairs—advancing the therapeutic index of CRISPR technology. Biotechnol J. 2018;13:e1700432.
Trapani I, Toriello E, de Simone S, Colella P, Iodice C, Polishchuk EV, et al. Improved dual AAV vectors with reduced expression of truncated proteins are safe and effective in the retina of a mouse model of Stargardt disease. Hum Mol Genet. 2015;24:6811–25.
Acknowledgements
The authors are grateful to Graciana Diez-Roux (TIGEM Scientific Office) for the critical reading of the manuscript.
Funding
AA is funded by Fondazione Telethon, the European Research Council (ERC) (grant number 694323 “EYEGET”) and by the European Union Horizon 2020 and Marie Curie programs (grants number: 825825 “Upgrade” and 813490 “StarT”, respectively). IT receives funding from University of Naples Federico II, STAR Program.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
IT, PT and AA are co-inventors on patents related to both dual AAV and AAV intein vectors.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Trapani, I., Tornabene, P. & Auricchio, A. Large gene delivery to the retina with AAV vectors: are we there yet?. Gene Ther 28, 220–222 (2021). https://doi.org/10.1038/s41434-020-0174-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41434-020-0174-4
This article is cited by
-
Gentherapie in der Augenheilkunde
Die Ophthalmologie (2023)
-
mRNA trans-splicing dual AAV vectors for (epi)genome editing and gene therapy
Nature Communications (2023)
-
An efficient rAAV vector for protein expression in cortical parvalbumin expressing interneurons
Scientific Reports (2022)
-
Maybe you can turn me on: CRISPRa-based strategies for therapeutic applications
Cellular and Molecular Life Sciences (2022)
-
Gene therapy in color vision deficiency: a review
International Ophthalmology (2021)